Xbiotech

XBIT · NASDAQ · Pharmaceutical Preparations

Xbiotech (XBIT) · oqro.io/stocks/XBIT · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.

How this filing works

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Want the short version?

Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.

Explain this page What did insiders at XBIT buy and sell in the last 90 days?Which members of Congress and which funds traded XBIT recently?

Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.

Insider trades around earnings

2 open-market purchases and 0 open-market sales by insiders of XBIT between Jun 29, 2015 and today, placed against the company's last 1 earnings release. The latest on file was filed Jul 29, 2015. The data provider lists the next release for Mar 11, 2027; that date may change.

PurchaseSale30 days before a release30 days after

Trades in the 30 days around each of the last earnings releases
Earnings release	30 days before	On the day	30 days after
Jul 29, 2015	None	None	None

John Simard, Director, Nov 3, 2026, about $143K. No earnings release within 120 days of this trade is on file.Form 4
John Simard, Director, Oct 26, 2026, about $711K. No earnings release within 120 days of this trade is on file.Form 4

Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies